Kugusheva L I, Rozengart V I
Ukr Biokhim Zh (1978). 1986 May-Jun;58(3):13-8.
Differences are found between the membrane-bound and soluble acetylcholinesterases of human and bovine erythrocytes when the enzyme interacts with organophosphoric inhibitors in the presence of acetylc choline and galantamine, a reverse inhibitor of acetylcholinesterase. In most cases prevention of inhibition of the soluble enzyme activity necessitates a higher (2-3 times higher) concentration of the protecting agent than protection of the membrane-bound enzyme. Concentrations of acetylcholine and galantamine providing a 50% protection of the enzyme did not practically depend on the strength of the anticholinesterase action of organophosphoric inhibitors.
当乙酰胆碱酯酶在乙酰胆碱和加兰他敏(一种乙酰胆碱酯酶的反向抑制剂)存在的情况下与有机磷酸酯抑制剂相互作用时,在人和牛红细胞的膜结合型与可溶性乙酰胆碱酯酶之间发现了差异。在大多数情况下,与保护膜结合型酶相比,防止可溶性酶活性受到抑制需要更高(高2 - 3倍)浓度的保护剂。提供50%酶保护作用的乙酰胆碱和加兰他敏浓度实际上并不取决于有机磷酸酯抑制剂的抗胆碱酯酶作用强度。